Biotalys Management
Management criteria checks 2/4
We currently do not have sufficient information about the CEO.
Key information
Kevin Helash
Chief executive officer
€415.1k
Total compensation
| CEO salary percentage | 22.2% |
| CEO tenure | 1.2yrs |
| CEO ownership | n/a |
| Management average tenure | 1.3yrs |
| Board average tenure | 4.2yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | -€16m |
| Mar 31 2024 | n/a | n/a | -€18m |
| Dec 31 2023 | €415k | €92k | -€21m |
Compensation vs Market: Kevin's total compensation ($USD430.37K) is about average for companies of similar size in the German market ($USD470.78K).
Compensation vs Earnings: Insufficient data to compare Kevin's compensation with company performance.
CEO
Kevin Helash (59 yo)
1.2yrs
Tenure
€415,093
Compensation
Mr. Kevin R. Helash is the Chief Executive Officer of Biotalys NV from October 2023 and serves as its Executive Director since March 29, 2024. Mr. Helash served as Chief Executive Officer at Marrone Bio In...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Executive Director | 1.2yrs | €415.09k | no data | |
| Chief Financial Officer | 1.4yrs | no data | no data | |
| Chief Scientific Officer | 2.6yrs | no data | no data | |
| Head of Investor Relations & Communication | no data | no data | no data | |
| Chief Business Development Officer | less than a year | no data | no data |
1.3yrs
Average Tenure
Experienced Management: 86C's management team is not considered experienced ( 1.3 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Executive Director | less than a year | €415.09k | no data | |
| Independent Chairman | 3.7yrs | €92.25k | no data | |
| Non-Executive Director | 5.9yrs | no data | no data | |
| Independent Non-Executive Director | 11.9yrs | €61.04k | no data | |
| Member of the Scientific Advisory Board | 4.7yrs | no data | no data | |
| Independent Director | 3.4yrs | €61.04k | no data | |
| Chairman of Scientific Advisory Board | 4.7yrs | no data | no data | |
| Non Executive Independent Director | 2.5yrs | €61.04k | no data | |
| Member of the Scientific Advisory Board | 4.7yrs | no data | no data | |
| Member of the Scientific Advisory Board | 4.7yrs | no data | no data | |
| Member of Scientific Advisory Committee | 2yrs | no data | no data | |
| Independent Director | less than a year | no data | no data |
4.2yrs
Average Tenure
64.5yo
Average Age
Experienced Board: 86C's board of directors are considered experienced (4.2 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/19 16:44 |
| End of Day Share Price | 2024/12/19 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Biotalys NV is covered by 3 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Sebastian Bray | Berenberg |
| Guy Sips | KBC Securities NV |
| Thomas Vranken | KBC Securities NV |